Cleerly LABS vs 1CMR Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS
by Mycardium AI Limited

AI Verdict

These tools are adjacent competitors, both leveraging AI for cardiac analysis but focusing on different imaging modalities and clinical applications. Cleerly LABS specializes in comprehensive coronary CT angiography (CCTA) analysis for atherosclerosis and stenosis, while 1CMR Pro enhances Cardiac MRI reporting for volumetric and functional measurements. Therefore, the choice depends on whether the clinical need is for coronary artery disease assessment via CCTA or broader cardiac function analysis via MRI.

Choose Cleerly LABS if…

Choose Cleerly LABS if your primary objective is a comprehensive, AI-powered analysis of Coronary CT Angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis. This tool is ideal for clinicians focused on personalized heart disease risk assessment, tracking disease progression over time, and understanding the specific nature of coronary plaque beyond simple stenosis.

View Cleerly LABS →

Choose 1CMR Pro if…

Choose 1CMR Pro if your institution requires highly precise, AI-enhanced Cardiac MRI reporting with a strong emphasis on automated volumetric and functional measurements. This software is best suited for environments prioritizing local data processing and seeking to improve the speed, accuracy, and consistency of CMR analysis while maintaining clinician control over editable contours.

View 1CMR Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly LABS 1CMR Pro
Pricing Per analysis Contact for pricing
Deployment Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. On-premise (software installed on hospital's own computer, processing data locally via a secure web-based platform)
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

1CMR Pro

While Cleerly LABS is a web-based application designed for intuitive use, 1CMR Pro explicitly highlights 'transparent and editable contours for clinician control'. This feature directly enhances usability by fostering clinician trust and allowing for review and adjustment of AI-generated segmentations, which is crucial in a clinical diagnostic setting.

Clinical Value

Tie

Both tools offer significant clinical value within their respective imaging modalities, backed by FDA clearance and clinical validation. Cleerly LABS provides comprehensive CCTA analysis for plaque characterization and personalized risk assessment, aiming to prevent heart attacks. 1CMR Pro enhances the precision and consistency of Cardiac MRI reporting, leading to more accurate and efficient diagnoses. Their distinct applications make a direct comparison of overall clinical value challenging.

Pricing & Value

Cleerly LABS

Cleerly LABS offers transparent, per-analysis pricing, allowing potential users to understand the cost upfront, even if it's a premium. In contrast, 1CMR Pro's pricing is not publicly disclosed, which makes it difficult to assess its value without direct inquiry. This lack of transparency can be a barrier for organizations evaluating solutions.

Enterprise Readiness

Cleerly LABS

Cleerly LABS explicitly states HIPAA compliance and provides a Business Associate Agreement (BAA), which are critical for enterprise adoption in healthcare. While 1CMR Pro's on-premise deployment and local data processing are strong for data security, the absence of an explicit HIPAA compliance statement and BAA makes it less definitively 'enterprise-ready' from a documentation and compliance standpoint compared to Tool A.

Innovation

Cleerly LABS

Cleerly LABS aims to establish a 'new standard of care' by leveraging AI for comprehensive CCTA analysis, focusing on early detection, plaque characterization, and personalized risk assessment to prevent heart attacks. This represents a more transformative approach to cardiovascular disease management. While 1CMR Pro offers significant advancements in CMR precision and automation, its innovation appears more focused on enhancing existing diagnostic workflows rather than redefining care pathways.

Support & Docs

Tie

Both Cleerly LABS and 1CMR Pro indicate that they offer customer support and documentation. However, the provided information for both tools is general and lacks specific details regarding the depth, availability, or quality of their support and documentation. Without more granular information, it is not possible to definitively pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly LABS 1CMR Pro
Tool Name Cleerly LABS 1CMR Pro
Company Cleerly Mycardium AI Limited
Imaging Modality Coronary CT angiography (CCTA) Cardiac MRI
Core AI Functionality AI-powered CCTA image analysis, comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with Cleerly ISCHEMIA module), 3D visualization. AI-enhanced Cardiac MRI Reporting, automated volumetric and functional measurements, convolutional neural networks trained on extensive datasets.
Data Processing Location Cloud-based (AWS) with on-site Cleerly Proxy for data transfer. Local data processing (no patient data transmitted beyond institution).

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and 1CMR Pro.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly LABS is designed for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis. In contrast, 1CMR Pro by Mycardium AI is an AI-enhanced reporting software specifically for Cardiac MRI analysis, delivering automated volumetric and functional measurements.
Cleerly LABS focuses on comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, and personalized heart disease risk assessment, with an optional module for ischemia detection. 1CMR Pro provides AI-enhanced Cardiac MRI reporting with automated volumetric and functional measurements, aiming for faster and more consistent analysis.
Cleerly LABS is FDA-cleared, HIPAA compliant, and has a Business Associate Agreement (BAA). 1CMR Pro is FDA 510(k) cleared and CE Class IIB cleared, and while it processes data locally within the institution and is ISO 27001 certified, an explicit HIPAA compliance statement or BAA for the product was not found.
Cleerly LABS uses AI-powered CCTA image analysis for comprehensive coronary plaque assessment and stenosis detection and quantification, with its accuracy demonstrated across multiple peer-reviewed, multicenter clinical studies. 1CMR Pro claims to deliver up to 40% more precise measurements than manual analysis for cardiac MRI, achieving enhanced precision and reproducibility through regulatory-grade automation and validation across multi-center datasets.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.